Note*: This report requires 7-10 business days to complete.
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Nonalcoholic Steatohepatitis (NASH) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Nonalcoholic Steatohepatitis (NASH) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Nonalcoholic Steatohepatitis (NASH) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Nonalcoholic Steatohepatitis (NASH) market.
• Identifying patient populations in the global “Nonalcoholic Steatohepatitis (NASH) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Nonalcoholic Steatohepatitis (NASH) therapeutics in each of the markets covered.
• To understand the future market competition in the global Nonalcoholic Steatohepatitis (NASH) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Nonalcoholic Steatohepatitis (NASH) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Nonalcoholic Steatohepatitis (NASH) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Nonalcoholic Steatohepatitis (NASH) Market
• Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Nonalcoholic Steatohepatitis (NASH) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) (2013-2023)
• Table 7: Nonalcoholic Steatohepatitis (NASH) Global Market (USD Millions), (2013-2015)
• Table 8: Nonalcoholic Steatohepatitis (NASH) Global Market (USD Millions), (2016-2023)
• Table 9: Nonalcoholic Steatohepatitis (NASH) US Market (USD Millions), (2013-2015)
• Table 10: Nonalcoholic Steatohepatitis (NASH) US Market (USD Millions), (2016-2023)
• Table 11: Nonalcoholic Steatohepatitis (NASH) Germany Market (USD Millions), (2013-2015)
• Table 12: Nonalcoholic Steatohepatitis (NASH) Germany Market (USD Millions), (2016-2023)
• Table 13: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Nonalcoholic Steatohepatitis (NASH) France Market (USD Millions), (2013-2015)
• Table 16: Nonalcoholic Steatohepatitis (NASH) France Market (USD Millions), (2016-2023)
• Table 17: Nonalcoholic Steatohepatitis (NASH) Italy Market (USD Millions), (2013-2015)
• Table 18: Nonalcoholic Steatohepatitis (NASH) Italy Market (USD Millions), (2016-2023)
• Table 19: Nonalcoholic Steatohepatitis (NASH) Spain Market (USD Millions), (2013-2015)
• Table 20: Nonalcoholic Steatohepatitis (NASH) Spain Market (USD Millions), (2016-2023)
• Table 21: Nonalcoholic Steatohepatitis (NASH) Japan Market (USD Millions), (2013-2015)
• Table 22: Nonalcoholic Steatohepatitis (NASH) Japan Market (USD Millions), (2016-2023)
• Table 23: Nonalcoholic Steatohepatitis (NASH) ROW Market (USD Millions), (2013-2015)
• Table 24: Nonalcoholic Steatohepatitis (NASH) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Nonalcoholic Steatohepatitis (NASH) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) (2013-2023)
• Figure 3: Nonalcoholic Steatohepatitis (NASH) Global Market (USD Millions), (2013-2015)
• Figure 4: Nonalcoholic Steatohepatitis (NASH) Global Market (USD Millions), (2016-2023)
• Figure 5: Nonalcoholic Steatohepatitis (NASH) US Market (USD Millions), (2013-2015)
• Figure 6: Nonalcoholic Steatohepatitis (NASH) US Market (USD Millions), (2016-2023)
• Figure 7: Nonalcoholic Steatohepatitis (NASH) Germany Market (USD Millions), (2013-2015)
• Figure 8: Nonalcoholic Steatohepatitis (NASH) Germany Market (USD Millions), (2016-2023)
• Figure 9: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Nonalcoholic Steatohepatitis (NASH) France Market (USD Millions), (2013-2015)
• Figure 12: Nonalcoholic Steatohepatitis (NASH) France Market (USD Millions), (2016-2023)
• Figure 13: Nonalcoholic Steatohepatitis (NASH) Italy Market (USD Millions), (2013-2015)
• Figure 14: Nonalcoholic Steatohepatitis (NASH) Italy Market (USD Millions), (2016-2023)
• Figure 15: Nonalcoholic Steatohepatitis (NASH) Spain Market (USD Millions), (2013-2015)
• Figure 16: Nonalcoholic Steatohepatitis (NASH) Spain Market (USD Millions), (2016-2023)
• Figure 17: Nonalcoholic Steatohepatitis (NASH) Japan Market (USD Millions), (2013-2015)
• Figure 18: Nonalcoholic Steatohepatitis (NASH) Japan Market (USD Millions), (2015-2023)
• Figure 19: Nonalcoholic Steatohepatitis (NASH) ROW Market (USD Millions), (2013-2015)
• Figure 20: Nonalcoholic Steatohepatitis (NASH) ROW Market (USD Millions), (2016-2023)
• Market (7MM)
• Market forecasting
• Sales forecasting
• Market segments
• Pipeline products and technologies
• Competitive landscape
• SWOT analysis
